Drug Therapy

Abelardo C. Cruz, MD
Division of Rheumatology, Department of Medicine, State University of New York at Stony Brook

Barry L. Gruber, MD
Head, Division of Rheumatology, Professor of Medicine and Dermatology, State University of New York at Stony Brook

Address: Abelardo C. Cruz, MD, State University of New York at Stony Brook, Division of Rheumatology, HSC T-16, Room 040, Stony Brook, NY 11794-8161; e-mail: [email protected]

Abelardo C. Cruz, MD
Division of Rheumatology, Department of Medicine, State University of New York at Stony Brook

Barry L. Gruber, MD
Head, Division of Rheumatology, Professor of Medicine and Dermatology, State University of New York at Stony Brook

Address: Abelardo C. Cruz, MD, State University of New York at Stony Brook, Division of Rheumatology, HSC T-16, Room 040, Stony Brook, NY 11794-8161; e-mail: [email protected]

Abelardo C. Cruz, MD
Division of Rheumatology, Department of Medicine, State University of New York at Stony Brook

Barry L. Gruber, MD
Head, Division of Rheumatology, Professor of Medicine and Dermatology, State University of New York at Stony Brook

Address: Abelardo C. Cruz, MD, State University of New York at Stony Brook, Division of Rheumatology, HSC T-16, Room 040, Stony Brook, NY 11794-8161; e-mail: [email protected]

Khavir A. Sharieff, DO
Inova Transplant Center at Inova Fairfax Hospital, Falls Church, VA

David Duncan, MD
Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Transplant Center and Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Rd., Falls Church, VA 22042; e-mail: [email protected]

Dr. Younossi has indicated that he has received grant or research support from the Roche and Schering-Plough corporations and is on the speakers’ bureaus of the Axcan Pharma, Roche, and Schering-Plough corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration (FDA) for the use under discussion.

Khavir A. Sharieff, DO
Inova Transplant Center at Inova Fairfax Hospital, Falls Church, VA

David Duncan, MD
Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Transplant Center and Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Rd., Falls Church, VA 22042; e-mail: [email protected]

Dr. Younossi has indicated that he has received grant or research support from the Roche and Schering-Plough corporations and is on the speakers’ bureaus of the Axcan Pharma, Roche, and Schering-Plough corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration (FDA) for the use under discussion.

Khavir A. Sharieff, DO
Inova Transplant Center at Inova Fairfax Hospital, Falls Church, VA

David Duncan, MD
Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Transplant Center and Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Rd., Falls Church, VA 22042; e-mail: [email protected]

Dr. Younossi has indicated that he has received grant or research support from the Roche and Schering-Plough corporations and is on the speakers’ bureaus of the Axcan Pharma, Roche, and Schering-Plough corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration (FDA) for the use under discussion.

Brian F. Mandell, MD, PhD
Deputy Editor, Cleveland Clinic Journal of Medicine; Department of Rheumatic and Immunologic Diseases; Senior Associate Program Director, Internal Medicine Residency Program, Cleveland Clinic

Victoria L. Vance
Attorney, Arter & Hadden, LLP, Cleveland, OH

Address: Brian F. Mandell, MD, PhD, FACR, Cleveland Clinic Journal of Medicine, NA32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Brian F. Mandell, MD, PhD
Deputy Editor, Cleveland Clinic Journal of Medicine; Department of Rheumatic and Immunologic Diseases; Senior Associate Program Director, Internal Medicine Residency Program, Cleveland Clinic

Victoria L. Vance
Attorney, Arter & Hadden, LLP, Cleveland, OH

Address: Brian F. Mandell, MD, PhD, FACR, Cleveland Clinic Journal of Medicine, NA32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Brian F. Mandell, MD, PhD
Deputy Editor, Cleveland Clinic Journal of Medicine; Department of Rheumatic and Immunologic Diseases; Senior Associate Program Director, Internal Medicine Residency Program, Cleveland Clinic

Victoria L. Vance
Attorney, Arter & Hadden, LLP, Cleveland, OH

Address: Brian F. Mandell, MD, PhD, FACR, Cleveland Clinic Journal of Medicine, NA32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Monica Acevedo, MD
Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Dennis L. Sprecher, MD, Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, C51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Monica Acevedo, MD
Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Dennis L. Sprecher, MD, Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, C51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Monica Acevedo, MD
Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Dennis L. Sprecher, MD, Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, C51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Peter Mazzone, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mani Kavuru, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Mani Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Kavuru has indicated that he has received grant or research support from the Immunex Corporation for research on GM-CSF.

Peter Mazzone, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mani Kavuru, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Mani Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Kavuru has indicated that he has received grant or research support from the Immunex Corporation for research on GM-CSF.

Peter Mazzone, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mani Kavuru, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Mani Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Kavuru has indicated that he has received grant or research support from the Immunex Corporation for research on GM-CSF.